Navigating the FDA’s Animal Rule in Drug Development with Modeling & Simulation
Shivani Sehta
Gaining regulatory approval for drugs targeting conditions that cannot ethically be studied in humans presents a unique challenge for drug developers. Without traditional clinical trial pathways, teams must rely on alternative methods to demonstrate efficacy and support approval. This webinar will explore how modeling and simulation are used to meet the requirements of the FDA […] The post Navigating the FDA’s Animal Rule in Drug Development with Modeling & Simulation appeared first on Allucent